<DOC>
	<DOCNO>NCT01804842</DOCNO>
	<brief_summary>This study compare effect delayed-release metformin ( Met DR , EFB0027 ) administer daily morning ( qAM ) , administer daily evening ( qPM ) , administer twice daily ( BID ) circulate glucose concentration metformin pharmacokinetics ( PK ) subject type 2 diabetes mellitus ( T2DM ) .</brief_summary>
	<brief_title>Assessing Effect Met DR Plasma Glucose PK Subjects With T2DM</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>1 . 18 70 ( inclusive ) year old Visit 1 ( Screening ) 2 . Was diagnose type 2 diabetes mellitus HbA1c 6.0 9.5 % ( inclusive ) subject manage diabetes : . Diet exercise alone , ii . A stable regimen ( minimum 2 month Visit 1 ) metformin alone , iii . A stable regimen ( minimum 2 month Visit 1 ) DPP4 inhibitor alone OR HbA1c 6.0 8.5 % ( inclusive ) subject manage diabetes stable ( minimum 2 month Visit 1 ) combination regimen metformin DPP4 inhibitor 3 . Had normal renal function estimate glomerular filtration rate ( eGFR ) â‰¥90 mL/min/1.73 m^2 base Modification Diet Renal Disease ( MDRD ) equation 4 . Body mass index ( BMI ) 25.0 40.0 kg/m^2 ( inclusive ) Screening 5 . Male , female meet follow criterion : Not breastfeed Negative pregnancy test result ( human chorionic gonadotropin , beta subunit ) Visit 1 ( Screening ) ( applicable hysterectomized female ) Surgically sterile , postmenopausal , childbearing potential , practice willing continue practice appropriate birth control entire duration study 6 . Had physical examination clinically significant abnormality judge investigator 7 . Ability understand willingness adhere protocol requirement 8 . If chronic thyroid pharmacologic therapy , dose must stable least 3 month prior Visit 1 ( Screening ) , must thyroidstimulating hormone ( TSH ) test result normal range Visit 1 ( Screening ) 1 . Had clinically significant medical condition could potentially affect study participation and/or personal wellbeing , judge investigator , include limited following condition : Hepatic disease Renal disease Gastrointestinal disease Endocrine disorder except diabetes Cardiovascular disease Central nervous system diseases Psychiatric neurological disorder Organ transplantation Chronic acute infection Orthostatic hypotension , faint spell blackouts Allergy hypersensitivity 2 . Had chronic disease require medication adjust past 90 day ( subject could take acute intermittent overthecounter medication Tylenol , need ) 3 . Had drug treatment affect gastric pH ( prescription overthecounter ) , include antacid medication Rolaids Pepcid within 2 day Visit 1 ( Screening ) 4 . Had major surgery kind within 6 month Visit 1 ( Screening ) 5 . Had receive blood transfusion within 6 month Visit 1 ( Screening ) 6 . Had history &gt; 5 kg weight change within 3 month Visit 1 ( Screening ) 7 . Had clinical laboratory test ( clinical chemistry , hematology , urinalysis ) abnormality expect subject type 2 diabetes judge investigator clinically significant Visit 1 ( Screening ) 8 . Had physical , psychological , historical finding , investigator 's opinion , would make subject unsuitable study 9 . Abused drug alcohol history abuse investigator 's opinion would cause individual noncompliant study procedures 10 . Had donate blood within 3 month date first dose randomize study medication , plan donate blood study 11 . Used insulin within 3 month Visit 1 ( Screening ) 12 . Had receive GLP1 receptor agonist and/or thiazolidinedione treatment within 6 month Visit 1 ( Screening ) 13 . Had know intolerance metformin 14 . Had receive investigational drug within 2 month ( five halflives investigational drug , whichever great ) Visit 1 ( Screening ) 15 . Had know allergy hypersensitivity component study treatment 16 . Was employ Elcelyx Therapeutics , Inc. ( employee , temporary contract worker , designee company ) 17 . Smoked 10 cigarette per day , 3 cigar per day , 3 pipe per day , use 1 smokeless tobacco per week , use combination tobacco product approximate nicotine dos equivalent 10 cigarette per day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>